XenoPort

The GGV Capital Portfolio

XenoPort

Biopharmaceutical company focused on the treatment of neurological disorders

“GGV led our expansion-stage financing round and was a consistent and constructive contributor to our growth and development.” - Ronald W. Barrett, Ph.D., Co-Founder & CEO

Next Company »